These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2527100)

  • 21. Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis.
    Leung DY; Saryan JA; Frankel R; Lareau M; Geha RS
    J Clin Invest; 1983 Oct; 72(4):1482-6. PubMed ID: 6226679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated B lymphocytes: stimulators of an augmented autologous mixed leukocyte reaction.
    Crow MK; Kunkel HG
    Cell Immunol; 1985 Feb; 90(2):555-68. PubMed ID: 3155659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous mixed-lymphocyte reaction in man. XVII. In vitro effect of ion channel-blocking agents on the autologous mixed-lymphocyte response.
    Gupta S
    Cell Immunol; 1987 Feb; 104(2):290-5. PubMed ID: 2434246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.
    De Berardinis P; Londei M; Kahan M; Balsano F; Kontiainen S; Gale EA; Bottazzo GF; Feldmann M
    Clin Exp Immunol; 1988 Aug; 73(2):255-9. PubMed ID: 2972427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction.
    Haynes MK; Miller J; Fuller L
    Clin Exp Immunol; 1990 Oct; 82(1):174-80. PubMed ID: 2145104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus.
    Smolen JS; Siminovitch K; Luger TA; Steinberg AD
    Behring Inst Mitt; 1983 May; (72):135-42. PubMed ID: 6242332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal CD5+ B lymphocytes are poor stimulators in the autologous mixed lymphocyte reaction (AMLR).
    Fernandez LA; Cheng R; Sadek I; Nevill TJ; Macsween JM
    Clin Exp Immunol; 1997 Jun; 108(3):557-61. PubMed ID: 9182907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The autologous mixed lymphocyte reaction (AMLR) as a possible indicator of immunoregulation in chronic inflammatory periodontal disease.
    Seymour GJ; Boyatzis S; Powell RN
    J Clin Periodontol; 1986 Aug; 13(7):639-45. PubMed ID: 2944916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autologous mixed lymphocyte reactions in rheumatoid arthritis. Characterization of stimulator cells and the recognition unit for autoantigens on the responder cells.
    Førre O; Thoen J; Waalen K; Natvig B
    Behring Inst Mitt; 1983 May; (72):188-92. PubMed ID: 6242337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Culture and phenotype of activated T-cells from patients with type I diabetes mellitus.
    Hayward AR; Herberger M
    Diabetes; 1984 Apr; 33(4):319-23. PubMed ID: 6368290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
    Gessl A; Waldhäusl W
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis.
    Kimura S; Fujimoto N; Okada H
    Infect Immun; 1991 Dec; 59(12):4418-24. PubMed ID: 1834575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction.
    Tomonari K
    J Immunol; 1980 Mar; 124(3):1111-21. PubMed ID: 6444646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the autologous mixed lymphocyte reaction in kidney transplantation.
    Fuller L; Flaa C; Jaffe D; Strauss J; Kyriakides GK; Miller J
    J Clin Invest; 1983 May; 71(5):1322-30. PubMed ID: 6222068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. I. Proliferation of two distinct T-cell subsets.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1987 Aug; 40(2):165-70. PubMed ID: 2956198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of suppressor cells in the autologous mixed lymphocyte reaction.
    Fitzharris P; Knight RA
    Clin Exp Immunol; 1981 Oct; 46(1):185-95. PubMed ID: 6461452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous mixed lymphocyte reaction in man. XIV. Deficiency of the autologous mixed lymphocyte reaction in acquired immune deficiency syndrome (AIDS) and AIDS related complex (ARC). In vitro effect of purified interleukin-1 and interleukin-2.
    Gupta S; Gillis S; Thornton M; Goldberg M
    Clin Exp Immunol; 1984 Nov; 58(2):395-401. PubMed ID: 6238734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous mixed lymphocyte reaction in man. X. T-T autologous mixed lymphocyte reaction in young and aging humans.
    Gupta S
    J Clin Lab Immunol; 1984 Jun; 14(2):107-9. PubMed ID: 6235371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The suppressive effects of monocytes in the autologous mixed lymphocyte reaction.
    Fernandez LA; MacSween JM
    Immunology; 1981 Dec; 44(4):653-9. PubMed ID: 6459291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.